mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration

Ian Eder,Virginia Yu,Jacob Antonello,Fangyuan Chen,David Gau,Pooja Chawla,Marion Joy,Peter C. Lucas,David Boone,Adrian V. Lee,Partha Roy
DOI: https://doi.org/10.1091/mbc.e24-01-0008
2024-08-31
Molecular Biology of the Cell
Abstract:Molecular Biology of the Cell, Ahead of Print. Actin cytoskeletal dysregulation gives rise to metastatic dissemination of cancer cells. How activities of master transcriptional regulators of cytoskeletal genes are linked to tumor cell migration are not clearly understood. This study mechanistically investigates the impact of specific functional disruption of MRTF (a transcriptional co-factor of SRF) on breast cancer cell migration. A mechanism linking mDia2 to MRTF-dependent regulation of cell migration is uncovered and clinical evidence for the association between MRTF activity and increased malignancy in human breast cancer is provided. Findings from these studies justify future exploration of small molecule inhibitors of the MRTF-SRF transcriptional complex as potential therapeutic agents to treat breast cancer.
cell biology
What problem does this paper attempt to address?